Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil

Salles1, Isadora; Oliveira2, Jamile Garcia de; Souza3, Alexandra Brito de; Cohn1, Silvia; Spener-Gomes4,5, Renata; Andrade3, Solange Dourado de; Saraceni2, Valeria; Cavalcante2,6, Solange Cesar; Weiser7, Jeff; Gombe7, Makaita; Chihota7,8,9, Violet; Churchyard7,8,9, Gavin; Chaisson1, Richard E; Cordeiro-Santos3,4,10, Marcelo; Durovni2,11, Betina

393
Views

Back to summary

Open Access

Peer-Reviewed
Artigo Original

Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil

Isadora Salles1, Jamile Garcia de Oliveira2, Alexandra Brito de Souza3, Silvia Cohn1, Renata Spener-Gomes4,5, Solange Dourado de Andrade3, Valeria Saraceni2, Solange Cesar Cavalcante2,6, Jeff Weiser7, Makaita Gombe7, Violet Chihota7,8,9, Gavin Churchyard7,8,9, Richard E Chaisson1, Marcelo Cordeiro-Santos3,4,10, Betina Durovni2,11

How to cite this article

Salles1 I, Oliveira2 JG, Souza3 AB, Cohn1 S, Spener-Gomes4 R, 5 , et al. Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil. J Bras Pneumol. 2025;51(4):e20250125